Achieving Targeted Treatment Outcomes in IBD - Episode 6
Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease
Published on:
Silvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, highlight the common practice in many community settings of treating inflammatory bowel disease (IBD) with corticosteroids, with or without 5-aminosalicylic acid, and cycling patients through this regimen for prolonged periods, while emphasizing the significant impact and toxicities associated with this treatment approach.
- When should clinicians start thinking about starting advanced targeted therapies for patients with UC or CD?
